HbA1c Reduction
Evidence related to lowering or improving HbA1c/A1C in diabetes management.
- Studies
- 156
- Evidence
- Extensive Research
Explore diabetes-related outcomes, how they are measured, and which interventions affect them.
Last updated: July 11, 2026
Dediabetes organizes diabetes outcomes by interventions studied, evidence strength, research coverage, and validated evidence relationships.
Evidence related to lowering or improving HbA1c/A1C in diabetes management.
Evidence related to body weight reduction, BMI improvement, waist circumference, and body composition changes.
Evidence related to blood glucose control, fasting glucose, postprandial glucose, glucose variability, and time in range.
Evidence related to treatment adherence, medication use, physical activity participation, step count, diet intake, fruit and vegetable intake, and self-care behavior adherence.
Evidence related to inflammatory, oxidative stress, endothelial, and vascular biomarkers measured in diabetes studies.
Evidence related to physical activity levels and physical activity changes in diabetes studies.
Relevant to 3 evidence relationships in this category.
Relevant to 6 evidence relationships in this category.
Relevant to 4 evidence relationships in this category.
Relevant to 2 evidence relationships in this category.
Relevant to 3 evidence relationships in this category.
Relevant to 9 evidence relationships in this category.
Relevant to 7 evidence relationships in this category.
Relevant to 4 evidence relationships in this category.
Evidence for outcomes in Metabolic Health.
Evidence for outcomes in Glycemic Control.
Explore categoryEvidence for outcomes in Safety.
Explore categoryEvidence for outcomes in Patient Reported.
Explore categoryEvidence for outcomes in Weight & Anthropometrics.
Explore categoryEvidence for outcomes in Clinical Outcomes.
Explore categoryEvidence for outcomes in Adherence & Engagement.
Outcomes with the strongest supported intervention relationships.
Entity with the broadest research coverage in this index.
Entity connected to the most scored evidence relationships.
Top-ranked group relationships with strong or very strong evidence labels.
Backend-ranked relationships with public evidence and consistency score objects.
| Intervention | Outcome | EvidenceScore™ | ConsistencyScore™ | Studies | Explore |
|---|---|---|---|---|---|
| Metformin Therapies | HbA1c | 88/100 | 86/100 | 8 | Explore |
| GLP-1 Receptor Agonists | Body Weight | 86/100 | 96/100 | 25 | Explore |
| GLP-1 Receptor Agonists | HbA1c | 86/100 | 92/100 | 25 | Explore |
| Diabetes Self-Management Education and Support (DSMES) Programs | Fasting Glucose | 86/100 | 57/100 | 8 | Explore |
| GLP-1 Receptor Agonists | Cardiovascular Outcomes | 85/100 | 83/100 | 9 | Explore |
| Probiotics and Synbiotics | Fasting Glucose | 85/100 | 56/100 | 9 | Explore |
| Diabetes Self-Management Education and Support (DSMES) Programs | HbA1c | 85/100 | 67/100 | 26 | Explore |
| Diabetes Self-Management Education and Support (DSMES) Programs | Quality of Life Outcomes | 85/100 | 86/100 | 9 | Explore |
| Outcome group | Featured intervention group | Relationships | Studies | Evidence | Explore |
|---|---|---|---|---|---|
| HbA1c | Metformin Therapies | 58 | 101 | Strong | Browse |
| Body Weight | GLP-1 Receptor Agonists | 32 | 41 | Strong | Browse |
| Fasting Glucose | Diabetes Self-Management Education and Support (DSMES) Programs | 44 | 47 | Strong | Browse |
| Cardiovascular Outcomes | GLP-1 Receptor Agonists | 17 | 18 | Strong | Browse |
| Quality of Life Outcomes | Diabetes Self-Management Education and Support (DSMES) Programs | 16 | 18 | Strong | Browse |
| Insulin Resistance | Probiotics and Synbiotics | 35 | 30 | Strong | Browse |
| Diabetes Management Self-Efficacy | Diabetes Self-Management Education and Support (DSMES) Programs | 10 | 9 | Strong | Browse |
| Treatment Adherence | Diabetes Self-Management Education and Support (DSMES) Programs | 5 | 8 | Strong | Browse |
| Body Mass Index | Diabetes Self-Management Education and Support (DSMES) Programs | 28 | 34 | Strong | Browse |
| Adipokine and Angiogenic Markers | Probiotics and Synbiotics | 82 | 38 | Strong | Browse |
| Hypoglycemia | GLP-1 Receptor Agonists | 27 | 22 | Strong | Browse |
| Kidney Function | SGLT2 Inhibitors | 28 | 21 | Strong | Browse |
Metformin Therapies
GLP-1 Receptor Agonists
Diabetes Self-Management Education and Support (DSMES) Programs
GLP-1 Receptor Agonists
Diabetes Self-Management Education and Support (DSMES) Programs
Probiotics and Synbiotics
Diabetes Self-Management Education and Support (DSMES) Programs
Diabetes Self-Management Education and Support (DSMES) Programs
Diabetes Self-Management Education and Support (DSMES) Programs
Probiotics and Synbiotics
GLP-1 Receptor Agonists
SGLT2 Inhibitors
Browse 773 outcomes represented in the evidence graph.
Showing 1-25 of 773 outcomes
| Outcome | Category | Group | Studies | Interventions | Evidence | Explore |
|---|---|---|---|---|---|---|
| HbA1c | Glycemic Control | HbA1c | 180 | 132 | Strong | |
| Fasting Plasma Glucose (FPG) | Glycemic Control | Fasting Glucose | 49 | 48 | Strong | |
| Body weight | Weight & Anthropometrics | Body Weight | 55 | 45 | Strong | |
| BMI | Weight & Anthropometrics | Body Mass Index | 50 | 43 | Strong | |
| Insulin resistance | Metabolic Health | Insulin Resistance | 32 | 33 | Strong | |
| Fasting blood sugar (FBS) | Glycemic Control | Fasting Glucose | 29 | 27 | Strong | |
| Blood glucose | Glycemic Control | Fasting Glucose | 26 | 25 | Strong | |
| Quality of life | Patient-Reported | Quality of Life Outcomes | 24 | 23 | Strong | |
| Adverse events incidence | Safety | Adverse Events and Safety | 22 | 22 | Strong | |
| Waist circumference | Weight & Anthropometrics | Body Composition | 23 | 18 | Strong | |
| Diabetes self-management behaviors | Patient-Reported | Diabetes Management Self-Efficacy | 17 | 17 | Strong | |
| Composite cardiovascular events (CV death, MI, stroke, HF hospitalization) | Clinical Outcomes | Cardiovascular Outcomes | 15 | 14 | Strong | |
| All-cause mortality | Clinical Outcomes | Cardiovascular Outcomes | 17 | 12 | Strong | |
| Fasting insulin levels | Metabolic Health | Insulin Resistance | 16 | 12 | Strong | |
| Severe hypoglycemia | Safety | Hypoglycemia | 6 | 8 | Strong | |
| Malondialdehyde (MDA) | Metabolic Health | Oxidative Stress Markers | 9 | 7 | Strong | |
| Serum 25-hydroxyvitamin D | Metabolic Health | Adipokine and Angiogenic Markers | 7 | 5 | Strong | |
| Cardiovascular events | Clinical Outcomes | Cardiovascular Outcomes | 6 | 5 | Strong | |
| Nonfatal stroke | Clinical Outcomes | 3 | 2 | Strong | ||
| Serum concentration of vitamin D | Metabolic Health | 4 | 1 | Strong | ||
| Systolic blood pressure | Metabolic Health | Blood Pressure | 39 | 36 | Moderate | |
| Triglycerides | Metabolic Health | Adipokine and Angiogenic Markers | 35 | 36 | Moderate | |
| LDL cholesterol | Metabolic Health | Adipokine and Angiogenic Markers | 33 | 35 | Moderate | |
| Total cholesterol | Metabolic Health | Adipokine and Angiogenic Markers | 30 | 32 | Moderate | |
| Sleep quality | Patient-Reported | Quality of Life Outcomes | 22 | 25 | Moderate |
Glycemic Control - HbA1c
Glycemic Control - Fasting Glucose
Weight & Anthropometrics - Body Weight
Weight & Anthropometrics - Body Mass Index
Metabolic Health - Insulin Resistance
Glycemic Control - Fasting Glucose
Glycemic Control - Fasting Glucose
Patient-Reported - Quality of Life Outcomes
Safety - Adverse Events and Safety
Weight & Anthropometrics - Body Composition
Patient-Reported - Diabetes Management Self-Efficacy
Clinical Outcomes - Cardiovascular Outcomes
Clinical Outcomes - Cardiovascular Outcomes
Metabolic Health - Insulin Resistance
Safety - Hypoglycemia
Metabolic Health - Oxidative Stress Markers
Metabolic Health - Adipokine and Angiogenic Markers
Clinical Outcomes - Cardiovascular Outcomes
Clinical Outcomes
Metabolic Health
Metabolic Health - Blood Pressure
Metabolic Health - Adipokine and Angiogenic Markers
Metabolic Health - Adipokine and Angiogenic Markers
Metabolic Health - Adipokine and Angiogenic Markers
Patient-Reported - Quality of Life Outcomes